172 related articles for article (PubMed ID: 38468148)
1. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta-analysis of randomized controlled trials.
Haber R; Zarzour F; Ghezzawi M; Saadeh N; Bacha DS; Al Jebbawi L; Chakhtoura M; Mantzoros CS
Diabetes Obes Metab; 2024 May; 26(5):1850-1867. PubMed ID: 38468148
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.
Dodd JM; Grivell RM; Deussen AR; Hague WM
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010564. PubMed ID: 30039871
[TBL] [Abstract][Full Text] [Related]
4. Drug interventions for the treatment of obesity in children and adolescents.
Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
[TBL] [Abstract][Full Text] [Related]
5. Screening for Obesity and Intervention for Weight Management in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force.
O'Connor EA; Evans CV; Burda BU; Walsh ES; Eder M; Lozano P
JAMA; 2017 Jun; 317(23):2427-2444. PubMed ID: 28632873
[TBL] [Abstract][Full Text] [Related]
6. Diabetes drugs for nonalcoholic fatty liver disease: a systematic review.
Blazina I; Selph S
Syst Rev; 2019 Nov; 8(1):295. PubMed ID: 31783920
[TBL] [Abstract][Full Text] [Related]
7. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
[TBL] [Abstract][Full Text] [Related]
8. The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials.
Baziar N; Parohan M
Phytother Res; 2020 Mar; 34(3):464-474. PubMed ID: 31799714
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review.
Lentferink YE; Knibbe CAJ; van der Vorst MMJ
Drugs; 2018 Dec; 78(18):1887-1901. PubMed ID: 30511324
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial.
Guo W; Tian W; Lin L; Xu X
Diabetes Res Clin Pract; 2020 Dec; 170():108487. PubMed ID: 33035599
[TBL] [Abstract][Full Text] [Related]
11. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
Shyangdan D; Clar C; Ghouri N; Henderson R; Gurung T; Preiss D; Sattar N; Fraser A; Waugh N
Health Technol Assess; 2011 Nov; 15(38):1-110. PubMed ID: 22059955
[TBL] [Abstract][Full Text] [Related]
12. Green tea for weight loss and weight maintenance in overweight or obese adults.
Jurgens TM; Whelan AM; Killian L; Doucette S; Kirk S; Foy E
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD008650. PubMed ID: 23235664
[TBL] [Abstract][Full Text] [Related]
13. The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
Gkiourtzis N; Michou P; Moutafi M; Glava A; Cheirakis K; Christakopoulos A; Vouksinou E; Fotoulaki M
Eur J Pediatr; 2023 Nov; 182(11):4795-4806. PubMed ID: 37639015
[TBL] [Abstract][Full Text] [Related]
14. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
Jalali M; Rahimlou M; Mahmoodi M; Moosavian SP; Symonds ME; Jalali R; Zare M; Imanieh MH; Stasi C
Pharmacol Res; 2020 Sep; 159():104799. PubMed ID: 32278041
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis.
Nieuwenhuis-Ruifrok AE; Kuchenbecker WK; Hoek A; Middleton P; Norman RJ
Hum Reprod Update; 2009; 15(1):57-68. PubMed ID: 18927072
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy weight-loss interventions to prevent type 2 diabetes in overweight or obese adults and older adults: A protocol for systematic review and network meta-analysis.
Yang W; Wen J; Wu F; Zeng H; Guo B; Ge L
Medicine (Baltimore); 2021 Mar; 100(11):e24812. PubMed ID: 33725948
[TBL] [Abstract][Full Text] [Related]
17. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
19. The effect of orlistat in the treatment of non-alcoholic fatty liver in adolescents with overweight and obese.
Zahmatkesh A; Sohouli MH; Shojaie S; Rohani P
Eur J Pediatr; 2024 Mar; 183(3):1173-1182. PubMed ID: 38081992
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
